Liraglutide improves hepatic insulin resistance via the canonical Wnt signaling pathway

Qin, Y; Chen, M; Yang, Y; Zhou, XR; Shao, SY; Wang, DW; Yuan, G

Wang, DW; Yuan, G (reprint author), Huazhong Univ Sci & Technol, Tongji Hosp, Dept Internal Med, 1095 Jiefang Rd, Wuhan 430030, Hubei, Peoples R China.

MOLECULAR MEDICINE REPORTS, 2018; 17 (5): 7372

Abstract

Liraglutide, a modified form of glucagon-like peptide-1 (GLP-1), is used in the treatment of diabetes mellitus. However, the underlying mechanism by w......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索